STAT3 and cancer: As shown in Supplementary Fig. 6A, low dose (100 nM) STAT3i treatment showed significant downregulation of STAT3 and pSTAT3 in nicotine-activated neutrophils in comparison to cancer cells that showed no diminished STAT3 expression nor reduced cell viability at the same dose (Supplementary Fig. 6B, C).